Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...
SurvivorNet on MSN
A simpler delivery system: FDA approves subcutaneous injection version of powerful targeted drug isatuximab for multiple myeloma
A new underтАСtheтАСskin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
According to Carney, who was present for his birth, Tornado was the biggest puppy of the litter and has lived up to his name ...
(NYSE: ZTS) today announced that it has recently launched Lenivia ® (izenivetmab injection) in Canada and the Europea ...
The FDA has approved a subcutaneous version of isatuximab (Sarclisa Escena, Sanofi-Aventis) for several multiple myeloma (MM) ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
SanofiтАЩs subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a ...
рдЕрдм рддрдХ рдирд╛рдЧрд░рд┐рдХ рдЕрд╕реНрдкрддрд╛рд▓ рдореЗрдВ рд░реИрдмреАрдЬ рдХреЗ 194 рдорд╛рдорд▓реЗ рд╕рд╛рдордиреЗ рдЖрдП рд╣реИрдВред рдЗрдирдореЗрдВ 10 рд▓реЛрдЧреЛрдВ рдХреЛ рдмрд┐рд▓реНрд▓рд┐рдпреЛрдВ рдФрд░ 17 рд▓реЛрдЧреЛрдВ рдХреЛ ...
рдХрд╛рдирдкреБрд░ рджреЗрд╣рд╛рдд рдХреЗ рд░рд╛рдЬрдкреБрд░ рдХрд╕реНрдмреЗ рдФрд░ рдЖрд╕рдкрд╛рд╕ рдХреЗ рдЧреНрд░рд╛рдореАрдг рдЗрд▓рд╛рдХреЛрдВ рдореЗрдВ рдХреБрддреНрддреЛрдВ рдФрд░ рдмрдВрджрд░реЛрдВ рдХрд╛ рдЖрддрдВрдХ рдмрдврд╝ рдЧрдпрд╛ рд╣реИ ...
рдЖрд╖реНрдЯрд╛ рдмреНрд▓реЙрдХ рдХреЗ рд╕рдмрд╕реЗ рдмрдбрд╝реЗ рд╕рд┐рд╡рд┐рд▓ рдЕрд╕реНрдкрддрд╛рд▓ рдореЗрдВ рд╕реНрд╡рд╛рд╕реНрдереНрдп рд╡реНрдпрд╡рд╕реНрдерд╛рдПрдВ рдмрд┐рдЧрдбрд╝рддреА рдЬрд╛ рд░рд╣реА рд╣реИрдВред рдпрд╣рд╛рдВ рд░реЗрдмреАрдЬ рдХрд╛ ...
This video breaks down SubQ, a new LLM architecture claiming massive efficiency gains through subquadratic sparse attention. It explains how SubQ could handle up to 12 million tokens, reduce compute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results